BACKGROUND AND AIM: A subcirrhotic range of liver stiffness (sc-LS), assessed by transient elastography, is associated with better outcomes in patients with chronic hepatitis B (CHB). We investigated whether the achievement of sc-LS by antiviral therapy (AVT) reduced the risk of developing hepatocellular carcinoma (HCC) in patients with CHB-related advanced fibrosis or cirrhosis. METHODS: In total, 209 patients with CHB-related advanced fibrosis or cirrhosis, who received paired transient elastography examinations during AVT between 2007 and 2012, were enrolled. The cut-off LS value for ultrasonographic cirrhosis was defined as 11.6 kPa. RESULTS: The median age of the study population was 51 years, with males predominating (n = 138, 66.0%)....
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Objective: The liver stiffness-based risk prediction models predict hepatocellular carcinoma (HCC) d...
BACKGROUND AND AIMS: The risk of developing hepatocellular carcinoma (HCC) varies, even in the conte...
Background: Dynamic changes in fibrosis markers occur under long-term antiviral treatment (AVT) for ...
BACKGROUNDS/AIMS: Monitoring fibrosis is mandatory for detailed prognostification in patients with c...
The severity of liver fibrosis can be noninvasively evaluated by measuring liver stiffness (LS) usin...
Liver stiffness measurement (LSM) using FibroScan accurately assesses the degree of liver fibrosis a...
Early detection of liver cirrhosis in its subclinical stage is of paramount importance to identify h...
The severity of liver fibrosis can be noninvasively evaluated by measuring liver stiffness (LS) usin...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background/Aims: To investigate the use of measurements of liver stiffness (LS) by two-dimensional r...
Background & Aims: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces ...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Objective: The liver stiffness-based risk prediction models predict hepatocellular carcinoma (HCC) d...
BACKGROUND AND AIMS: The risk of developing hepatocellular carcinoma (HCC) varies, even in the conte...
Background: Dynamic changes in fibrosis markers occur under long-term antiviral treatment (AVT) for ...
BACKGROUNDS/AIMS: Monitoring fibrosis is mandatory for detailed prognostification in patients with c...
The severity of liver fibrosis can be noninvasively evaluated by measuring liver stiffness (LS) usin...
Liver stiffness measurement (LSM) using FibroScan accurately assesses the degree of liver fibrosis a...
Early detection of liver cirrhosis in its subclinical stage is of paramount importance to identify h...
The severity of liver fibrosis can be noninvasively evaluated by measuring liver stiffness (LS) usin...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background/Aims: To investigate the use of measurements of liver stiffness (LS) by two-dimensional r...
Background & Aims: Hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs) reduces ...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Background: Direct-acting antivirals (DAA) are an effective treatment for hepatitis C virus infectio...
Objective: The liver stiffness-based risk prediction models predict hepatocellular carcinoma (HCC) d...